Conformational induction versus conformational selection: evidence from allosteric enhancers

R F Bruns¹

Affiliations

Comment

R F Bruns. Trends Pharmacol Sci. 1996 May.

. 1996 May;17(5):189; discussion 190-1.

doi: 10.1016/0165-6147(96)20027-6.

R F Bruns¹

¹ Central Nervous System Division, Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, IN 46285, USA.

No abstract available

Comment on

Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity.
Kenakin T. Kenakin T. Trends Pharmacol Sci. 1995 Jun;16(6):188-92. doi: 10.1016/s0165-6147(00)89020-3. Trends Pharmacol Sci. 1995. PMID: 7652927 Review.
Agonist-receptor efficacy. II. Agonist trafficking of receptor signals.
Kenakin T. Kenakin T. Trends Pharmacol Sci. 1995 Jul;16(7):232-8. doi: 10.1016/s0165-6147(00)89032-x. Trends Pharmacol Sci. 1995. PMID: 7667897 Review.